CLClinicLens

Emergency Medicine

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose | ClinicLens

The US Food and Drug Administration (FDA) approved another over-the-counter intranasal naloxone product, marketed as Rextovy, for the emergency treatment of opioid overdose.

Medical Literature · Updated

← Back to articles
This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.